FDA
approval
· 2023-05-17
FDA Approved: KABIVEN — Supplemental Application (Fresenius Kabi USA, LLC)
Summary
FDA approved a supplemental application for KABIVEN, a complete parenteral nutrition product, confirming its labeling and continued use for patients requiring p…
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
SUPPL AP for KABIVEN (DEXTROSE, SOYBEAN OIL, ELECTROLYTES, LYSINE, PHENYLALANINE, LEUCINE, VALINE, THREONINE, METHIONINE, ISOLEUCINE, TRYPTOPHAN, ALANINE, ARGININE, GLYCINE, PROLINE, HISTIDINE, GLUTAMIC ACID, SERINE, ASPARTIC ACID AND TYROSINE)